Cloudbrink addresses Citrix users’ network challenges in the hybrid workplace
Fast access solution removes network bottlenecks SAN FRANCISCO, April 18, 2023 (GLOBE NEWSWIRE) — Cloudbrink…
Month: April 2023
Wolters Kluwer Enablon releases new version of Vision Platform software
New version empowers organizations to navigate evolving risk and compliance landscape, and includes AI-powered regulatory…
Normalyze Expands Its Data-first Cloud Security Platform to Analyze Lineage and Track Data Flows Across Structured and Unstructured Datastores
New 2.0 capabilities with dynamic data visualization lets security teams analyze sensitive data in motion…
Ushur Launches Prepackaged Healthcare and Insurance Solutions to Deliver Fast Time to Value
SANTA CLARA, Calif., April 18, 2023 (GLOBE NEWSWIRE) — Ushur, the leader in AI-powered Customer…
CentralReach Announces the Launch of CR Care Coordinator, Its Patented, Parent Training Software Product that Enables Therapy Providers to Deliver Parent Training at Scale – Empowering Families and Maximizing Positive Outcomes for Autistic
New CR Care Coordinator software helps parents learn ABA basics and other parenting skills via…
Optimas Appoints Industry Veteran Phil Battaglia as Chief Financial Officer
WOOD DALE, IL, Apr 18, 2023 – (ACN Newswire) – Optimas Solutions, a global industrial…
The 21st Conference on International Exchange of Professionals Opens in Shenzhen
SHENZHEN, CHINA, Apr 18, 2023 – (ACN Newswire) – On April 15, the 21st Conference…
Committed to Empowering Customers’ Transition to Net Zero, INNIO Opens Two Training Centers in China
GUANGDONG, CHINA, Apr 18, 2023 – (ACN Newswire) – INNIO Group today announced that it…
Three Weeks Until ISDA’s 37th AGM in Chicago – Did You Register?
–(BUSINESS WIRE)–#BenchmarkReform–Join the International Swaps and Derivatives Association, Inc. (ISDA) at its 37th Annual General…
Technology as a Driver in CX Transformation and Business Growth
By Brett Sharp, Sr. Director of Customer Experience, Synoptek Customer Experience (CX) strategy is critical…
SumUp Announces New Global ESG Initiatives To Support Sustainability Efforts
12 April 2023, London: Global financial technology company SumUp (https://www.sumup.com/en-gb/) continues its industry-leading sustainability agenda,…
Cycode Launches Application Security Orchestration and Correlation Solution to Streamline Vulnerability Testing and Remediation
Cycode ASOC Dashboard Cycode Launches Application Security Orchestration and Correlation (ASOC) Solution to Streamline Vulnerability…
Cycode Launches Application Security Orchestration and Correlation Solution to Streamline Vulnerability Testing and Remediation
Cycode ASOC Dashboard Cycode Launches Application Security Orchestration and Correlation (ASOC) Solution to Streamline Vulnerability…
Second Edition of Best-Selling Book, How to Measure Anything in Cyber Risk, Launches Globally
Author Richard Seiersen provides a start-to-finish guide for realistically measuring cybersecurity risk, a core step…
SOLVE FSHD Invests in Epic Bio to Advance Potentially Curative Therapy
– Investment will advance Epic’s lead program, EPI-321, toward clinic in 2024 – SOUTH SAN…
SOLVE FSHD Invests in Epic Bio to Advance Potentially Curative Therapy
– Investment will advance Epic’s lead program, EPI-321, toward clinic in 2024 – SOUTH SAN…
EvolveImmune Therapeutics Reports First Results from CRISPR-Cas9 T Cell Exhaustion Screening Platform at American Association for Cancer Research (AACR) Annual Meeting 2023
Novel Technology Identified Genes that Promote T Cell Exhaustion, and which are Unique from PD-1/PD-L1…
EvolveImmune Therapeutics Reports First Results from CRISPR-Cas9 T Cell Exhaustion Screening Platform at American Association for Cancer Research (AACR) Annual Meeting 2023
Novel Technology Identified Genes that Promote T Cell Exhaustion, and which are Unique from PD-1/PD-L1…
Erasca Presents Promising Initial Phase 1b Dose Escalation Data from FLAGSHP-1 for ERAS-601 Plus Cetuximab in Patients with Advanced Solid Tumors at the 2023 AACR Annual Meeting
ERAS-601, a potential best-in-class SHP2 inhibitor, blocks oncogenic signal transduction to delay onset of therapeutic…
Erasca Presents Promising Initial Phase 1b Dose Escalation Data from FLAGSHP-1 for ERAS-601 Plus Cetuximab in Patients with Advanced Solid Tumors at the 2023 AACR Annual Meeting
ERAS-601, a potential best-in-class SHP2 inhibitor, blocks oncogenic signal transduction to delay onset of therapeutic…